Belfast · Northern Ireland
TheBELFAST HERALDLocal knowledge. National perspective.
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works
HealthPremium archive

Australian government signs an agreement with Merck Sharp & Dohme to buy 300,000 courses of the antiviral drug molnupiravir, pending regulator clearance,

The Australian government signs an agreement with Merck Sharp & Dohme to buy 300,000 courses of the antiviral drug molnupiravir, pending regulator clearance, which would be the first pill to treat COVID-19 patients.

By Belfast Herald Newsdesk1 min read

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthAustralian government signs an agreement with Merck Sharp & Dohme to buy 300,000 courses of the antiviral drug molnupiravir, pending regulator clearance,

The Australian government signs an agreement with Merck Sharp & Dohme to buy 300,000 courses of the antiviral drug molnupiravir, pending regulator clearance, which would be the first pill to treat COVID-19 patients.

View Premium plansBrowse free archive reports